R1 RCM (RCM) Trading Down 5.5%

Shares of R1 RCM Inc (NASDAQ:RCM) fell 5.5% during mid-day trading on Friday . The company traded as low as $8.45 and last traded at $8.76. 1,092,180 shares were traded during mid-day trading, an increase of 73% from the average session volume of 631,029 shares. The stock had previously closed at $9.27.

A number of research firms have issued reports on RCM. BidaskClub lowered R1 RCM from a “buy” rating to a “hold” rating in a report on Saturday, October 13th. Zacks Investment Research raised R1 RCM from a “strong sell” rating to a “hold” rating in a report on Wednesday, July 18th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $10.00 target price on shares of R1 RCM in a report on Friday, July 27th. TheStreet raised R1 RCM from a “d+” rating to a “c” rating in a report on Tuesday, September 4th. Finally, Chardan Capital began coverage on R1 RCM in a report on Tuesday, September 4th. They issued a “buy” rating and a $17.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $11.05.

The firm has a market capitalization of $854.56 million, a price-to-earnings ratio of -19.91 and a beta of -0.32. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.08 and a quick ratio of 1.08.

R1 RCM (NASDAQ:RCM) last announced its quarterly earnings data on Wednesday, November 7th. The financial services provider reported ($0.17) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.05) by ($0.12). R1 RCM had a negative return on equity of 52.71% and a negative net margin of 11.31%. The firm had revenue of $250.40 million for the quarter, compared to analyst estimates of $240.09 million. During the same period in the previous year, the business posted ($0.08) EPS. R1 RCM’s revenue for the quarter was up 103.2% compared to the same quarter last year. On average, equities research analysts anticipate that R1 RCM Inc will post -0.17 earnings per share for the current year.

In other news, Director Albert Rene Zimmerli acquired 10,000 shares of the firm’s stock in a transaction dated Thursday, September 6th. The shares were bought at an average price of $9.73 per share, with a total value of $97,300.00. Following the acquisition, the director now owns 10,000 shares of the company’s stock, valued at $97,300. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 59.40% of the stock is currently owned by company insiders.

Large investors have recently made changes to their positions in the company. Cubist Systematic Strategies LLC acquired a new stake in shares of R1 RCM during the 1st quarter worth approximately $100,000. GSA Capital Partners LLP bought a new position in shares of R1 RCM during the 2nd quarter worth approximately $122,000. Oppenheimer Asset Management Inc. bought a new position in shares of R1 RCM during the 3rd quarter worth approximately $126,000. WINTON GROUP Ltd bought a new position in shares of R1 RCM during the 3rd quarter worth approximately $139,000. Finally, Teacher Retirement System of Texas bought a new position in shares of R1 RCM during the 2nd quarter worth approximately $147,000. 49.80% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: “R1 RCM (RCM) Trading Down 5.5%” was first published by WKRB News and is owned by of WKRB News. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at https://www.wkrb13.com/2018/11/10/r1-rcm-rcm-trading-down-5-5.html.

R1 RCM Company Profile (NASDAQ:RCM)

R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.

Featured Article: Yield Curve

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply